|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
Frank offers a disturbing look into medical malpractice and its effect on drug development and medical progress. He argues that fraudulent malpractice suits have become pervasive and, as a result, safe and effective medical treatments have been taken from the market and medical innovation has suffered as companies avoid products viewed as litigation magnets.
Is there a masstort case where fraud has not been a substantial factor? Good products like Bendectin have been driven from the American market because of litigation driven by junk science. When companies like Wyeth and Congoleum try to arrange settlements, they become chum in the water and find their resources drained by thousands of fraudulent claims of injury.
|home spotlight commentary research events news about contact links archives|